Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors

British Journal of Pharmacology

Volumn 137, Issue 8, 2002, Pages 1355-1361

  Flau, K ^a   Redmer, A ^a   Liedtke, S ^a   Kathmann, M ^a   Schlicker, E ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Ac RYYRIK NH 2; Dopamine release; Guinea pig retina; Mouse cerebral cortex; Naloxone benzoylhydrazone; Nociceptin; NOP receptor; Noradrenaline release; Orphanin FQ; Striatum

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE; NALOXONE BENZOYLHYDRAZONE; NOCICEPTIN;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG INHIBITION; EVOKED AUDITORY RESPONSE; GUINEA PIG; IN VITRO STUDY; INCUBATION TIME; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; STRIATE CORTEX;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; GUINEA PIGS; MALE; MICE; OPIOID PEPTIDES; RECEPTORS, OPIOID; RETINA;

EID: 0036945264     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704998     Document Type: Article

References (41)

1. 1) receptor. Naunyn-Schmiedeberg's Arch. Pharmacol., 359, 17-20.
2. 2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br. J. Pharmacol., 126, 555-558.
3. 2 selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain. J. Pharmacol. Exp. Ther., 294, 428-433.
4. Bigoni, R., Calo, G., Rizzi, A., Guerrini, R., De Risi C., Hashimoto, Y., Hashiba, E., Lambert, D. & Regoli, D., (2000). In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist. Naunyn-Schmiedeberg's Arch. Pharmacol., 361, 565-568.
5. Bigoni, R., Calo, G., Rizzi, A., Okawa, H., Regoli, D., Smart, D. & Lambert, D.G. (2002). Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors. Can. J. Physiol. Pharmacol., 80, 407-412.
6. 1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 682-685.
7. Calo, G., Guerrini, R., Rizzi, A., Salvadori, S. & Regoli, D. (2000). Pharmacology of nociceptin and its receptor: A novel therapeutic agent. Br. J. Pharmacol., 129, 1261-1283.
8. + channels in rat periaqueductal gray slices. Neuropharmacology, 42, 987-992.
9. Cox, B.M., Chavkin, C., Christie, M.J., Civelli, O., Evans, C., Hamon, M.D., Hoellt, V., Kieffer, B., Kitchen, I., Mcknight, A.T., Meunier, J.C. & Portoghese, P.S. (2000). Opioid receptors. In The IUPHAR Compendium of Receptor Characterization and Classification. ed. Girdlestone, D. pp. 321-333. London: IUPHAR Media.
10. Dooley, C.T., Spaeth, C.G., Berzetei-Gurske, I.P., Craymer, K., Adapa, I.D., Brandt, S.R., Houghten, R.A. & Toll, L. (1997). Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J. Pharmacol. Exp. Ther., 283, 735-741.
11. Furchgott, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In Handbook of Experimental Pharmacology, Vol. XXXIII. ed. Blaschko, H. & Muscholl, E. pp 283-335. Berlin: Springer.
12. Hawes, B.E., Graziano, M.P. & Lambert, D.G. (2000). Cellular actions of nociceptin: Transduction mechanisms. Peptides, 21, 961-967.
13. 1 receptor on adrenergic nerves in the rat anococcygeus muscle. Br. J. Pharmacol., 131, 349-355.
14. Jenck, F., Moreau, J.L., Martin, J.R., Kilpatrick, G.J., Reinscheid, R.K., Monsma, F.J., Nothacker, H.P. & Civelli, O. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U.S.A., 94, 14854-14858.
15. Kawamoto, H., Ozaki, S., Itoh, Y., Miyaji, M., Arai, H., Nakashima, H., Kaio, T., Ohia, H. & Iwasawa, Y. (1999). Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctyl-methyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397). J. Med. Chem., 42, 5061-5063.
16. Konya, H., Masuda, H., Itoh, K., Nagai, K., Kakishita, E. & Matsuoka, A. (1998). Modification of dopamine release by nociceptin in conscious rat striatum. Brain Res., 788, 341-344.
17. Lutfy, K., Do, T. & Maidment, N.T. (2001). Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berlin), 154, 1-7.
18. Makman, M.H. & Dvorkin, B. (1997). Presence of nociceptin (orphanin FQ) receptors in rat retina: Comparison with receptors in striatum. Eur. J. Pharmacol., 338, 171-176.
19. 4 receptor agonist in the cardiovascular system of anesthetized rats. Peptides, 21, 1875-1880.
20. 1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 361, 80-84.
21. 1 receptors. Neuropeptides, 35, 244-256.
22. Mogil, J.S. & Pasternak, G.W. (2001). The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev., 53, 381-415.
23. Mollereau, C. & Mouledous, L. (2000). Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides, 21, 907-917.
24. Moran, T.D., Abdulla, F.A. & Smith, P.A. (2000). Cellular neurophysiological actions of nociceptin/orphanin FQ. Peptides, 21, 969-976.
25. Murphy, N.P., Ly, H.T. & Maidment, N.T. (1996). Intracerebro-ventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience, 75, 1-4.
26. Murphy, N.P. & Maidment, N.T. (1999). Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J. Neurochem., 73, 179-186.
27. Neal, M.J., Cunningham, J.R., Paterson, S.J. & Mcknight, A.T. (1997). Inhibition by nociceptin of the light-evoked release of ACh from retinal cholinergic neurones. Br. J. Pharmacol., 120, 1399-1400.
28. Noda, Y., Mamiya, T., Manabe, T., Nishi, M., Takeshima, H. & Nabeshima, T. (2000). Role of nociceptin systems in learning and memory. Peptides, 21, 1063-1069.
29. Oh, S., Kim, I., Lee, E., Kim, K., Kim, H. & Chun, M. (1999). Immunocytological localization of dopamine in the guinea-pig retina. Cell Tiss. Res., 298, 561-565.
30. Olianas, M.C. & Onali, P. (2002). Pharmacological properties of nociceptin/orphanin FQ-induced stimulation and inhibition of cyclic AMP formation in distinct layers of rat olfactory bulb. Br. J. Pharmacol., 135, 233-238.
31. Polidori, C., De Caro, G. & Massi, M. (2000). The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides, 21, 1051-1062.
32. Rominger, A., Förster, S., Zentner, J., Dooley, D.J., Mcknight, A.T., Feuerstein, T.J., Jackisch, R. & Vlaskovska, M. (2002). Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices. Br. J. Pharmacol., 135, 800-806.
33. 2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 639-646.
34. Schlicker, E. & Morari, M. (2000). Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides, 21, 1023-1029.
35. Schlicker, E., Werthwein, S. & Kathmann, M. (1998a). Orphan opioid receptor-mediated inhibition of noradrenaline, dopamine and serotonin release in the mouse, rat and guinea-pig brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 357 (Suppl.), R90.
36. 1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 418-422.
37. Shieh, K.R. & Pan, J.T. (2001). Effects of orphanin FQ on central dopaminergic neuronal activities and prolactin secretion. Am. J. Physiol. Regulatory Integrative Comp. Physiol., 280, R705-R712.
38. 3H]-5-HT release from rat cerebral cortex slices. Br. J. Pharmacol., 128, 119-123.
39. + conductance. Neuroendocrinology, 67, 73-82.
40. 1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro. Br. J. Pharmacol., 127, 300-308.
41. Zheng, F., Grandy, D.K. & Johnson, S.W. (2002). Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro. Br. J. Pharmacol., 136, 1065-1071.